Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )
Clinical trial NCT04371367 · COMPLETED
Trial details
- NCT number
- NCT04371367
- Sponsor
- Assistance Publique Hopitaux De Marseille
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-27
- Primary completion
- 2021-03-30
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.